Obesity and Inflammation and Altered Clopidogrel Pharmacokinetics and Pharmacodynamics

Conclusion: Comprehensive understanding of the mechanisms underlying obesity-related high onclopidogrel platelet reactivity will help in the optimization of antithrombotic therapy in this patient population.
Source: Drug Metabolism Letters - Category: Drugs & Pharmacology Source Type: research